» Articles » PMID: 26849802

A Mismatch Between High-Risk Behaviors and Screening of Infectious Diseases Among People Who Inject Drugs in Dar Es Salaam, Tanzania

Overview
Journal PLoS One
Date 2016 Feb 6
PMID 26849802
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: People who inject drugs are at risk of various infectious diseases. Despite such a risk, evidence is limited which studied the utilization of screening services for common infectious diseases among people who inject drugs in Tanzania. We aimed to examine their high-risk behaviors; utilization of screening services for HIV infection, hepatitis B/C, any other sexually transmitted infection, and tuberculosis; and their associated factors in Dar es Salaam, Tanzania.

Methods: We conducted a baseline cross-sectional study as part of a prospective cohort study of people who inject drugs. We included 578 participants comprising of new enrollees of the integrated methadone-assisted treatment program and those who were selected from the communities but not enrolled in the program. We interviewed new enrollees preceding their enrollment and receipt of services from the program. We measured participants' high-risk behaviors and their utilization of screening services. We analyzed the data descriptively and used multiple logistic regressions to identify the factors associated with ever being screened for infectious diseases.

Results: Of 578 participants, 14.2% shared injection needles. Of 547 sexually active participants, 37.5% had multiple sexual partners and only 17.4% used a condom. Of all participants, however, only 36.0% had ever been screened for HIV infection, 18.5% for tuberculosis, 11.8% for any other sexually transmitted infection, and 11.6% for hepatitis B/C. They were more likely to have ever been screened for HIV infection if they had education levels above primary education (adjusted odds ratio [AOR]: 2.54, 95% CI: 1.54-4.20), had a history of transactional sex (OR: 2.63, 95% CI: 1.01-6.84), and were new enrollees of the program (AOR: 7.41, 95% CI: 4.41-12.86).

Conclusions: People who inject drugs practice high-risk behaviors but their utilization of screening services for infectious diseases is poor in Dar es Salaam, Tanzania. It is crucial to increase the coverage of screening services for them and strengthen the counseling of safer sexual practices.

Citing Articles

Low engagement of key populations in HIV health services in Tanzania: analysis of community, legal and policy factors.

Kigombola A, Lyimo J, Mizinduko M, Mkembela D, Maziku E, Kafura W Pan Afr Med J. 2023; 45(Suppl 1):8.

PMID: 37538366 PMC: 10395107. DOI: 10.11604/pamj.supp.2023.45.1.39591.


Testing for Drug-Related Infectious Diseases and Determinants among People Who Use Drugs in a Low-Resource Setting: A Respondent-Driven Cross-Sectional Survey.

Likindikoki S, Mmbaga E, Mizinduko M, Alexander M, Adams L, Horsburgh Jr R Trop Med Infect Dis. 2022; 7(9).

PMID: 36136624 PMC: 9501249. DOI: 10.3390/tropicalmed7090213.


Structural, everyday, and symbolic violence and the heightened vulnerability to HIV of women who use drugs in Tanzania.

Saleem H, Zhang L, Silberg C, Latkin C, Likindikoki S SSM Qual Res Health. 2022; 1.

PMID: 35174337 PMC: 8846603. DOI: 10.1016/j.ssmqr.2021.100010.


Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.

Fraser H, Stone J, Wisse E, Sambu V, Mfisi P, Duran I J Int AIDS Soc. 2021; 24(10):e25817.

PMID: 34661964 PMC: 8522890. DOI: 10.1002/jia2.25817.


The Opioid Epidemic in Africa And Its Impact.

Kurth A, Cherutich P, Conover R, Chhun N, Bruce R, Lambdin B Curr Addict Rep. 2020; 5(4):428-453.

PMID: 32494564 PMC: 7269163. DOI: 10.1007/s40429-018-0232-9.


References
1.
Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S . Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic. Sex Transm Infect. 2009; 85 Suppl 2:ii17-22. DOI: 10.1136/sti.2008.034090. View

2.
Moreno S, Bouza E, Parras F, Miralles P, Vicente T, Alberdi J . Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med. 1993; 119(3):194-8. DOI: 10.7326/0003-4819-119-3-199308010-00003. View

3.
Du J, Lombardi C, Evans E, Jiang H, Zhao M, Meng Y . A mixed methods approach to identifying factors related to voluntary HIV testing among injection drug users in Shanghai, China. Int J Infect Dis. 2012; 16(7):e498-503. PMC: 3378774. DOI: 10.1016/j.ijid.2012.02.013. View

4.
Francis S, Ao T, Vanobberghen F, Chilongani J, Hashim R, Andreasen A . Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management. PLoS One. 2014; 9(7):e101221. PMC: 4099080. DOI: 10.1371/journal.pone.0101221. View

5.
Des Jarlais D, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N . "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr. 2004; 35(2):158-66. DOI: 10.1097/00126334-200402010-00010. View